BCI Marketplace
Depression Neuromodulation trials

Personalized Ultrasonic Brain Stimulation for Depression (R61)

RecruitingNCT06902298Phase: PHASE1, PHASE2Started 2025-03-10

Summary

This study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will be delivered using a range of stimulation parameters during psychological and physiological monitoring. Individualized optimal targets will be selected using structural MRI and diffusion tractography. Brain target engagement will be evaluated using functional MRI.

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
65 Years

Inclusion Criteria: 1. Age 18-65, any gender. 2. Primary diagnosis of DMS-5 major depressive disorder (MINI). 3. Current moderate-to-severe depressive episode, without psychotic features, lasting at least 2 months (MINI). 4. Self-rated 16-item Quick Inventory of Depressive Symptomatology (QIDS) tot

Locations

University of Utah
Salt Lake City, Utah, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →